Related Experiment Video

Updated: Apr 17, 2026

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
09:52

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Published on: December 28, 2017

11.2K

Cyclin-Dependent kinase 5 targeting prevents β-Amyloid aggregation involving glycogen synthase kinase 3β and

John Fredy Castro-Alvarez1, Alejandro Uribe-Arias1, Gloria Patricia Cardona-Gómez1

  • 1Cellular and Molecular Neurobiology Area, Neuroscience Group of Antioquia, Faculty of Medicine, SIU, University of Antioquia, Medellín, Colombia.

Journal of Neuroscience Research
|February 26, 2015
PubMed

Insights

Targeting cyclin-dependent kinase 5 (CDK5) reduces beta-amyloid aggregation in aged mice. Long-term CDK5 knockdown prevents amyloidosis, but may require booster therapy for sustained effects in Alzheimer

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Aberrant cyclin-dependent kinase 5 (CDK5) activity, due to p25 fragment release, drives neurofibrillary tangles, beta-amyloid (βA) aggregation, and neurodegeneration.
  • Alzheimer's disease pathogenesis involves complex molecular pathways including protein aggregation and chronic neuroinflammation.

Purpose of the Study:

  • To investigate the therapeutic potential of cyclin-dependent kinase 5 (CDK5) knockdown in mitigating beta-amyloid (βA) pathology in a transgenic mouse model of Alzheimer's disease.
  • To evaluate the short-term and long-term efficacy of CDK5 inhibition on βA aggregation and related molecular mechanisms.

Main Methods:

  • Utilized 3× Tg-AD transgenic mice at 18 months of age.
  • Administered short-term (3 weeks) and long-term (1 year) CDK5 knockdown interventions.
  • Analyzed βA aggregation, glycogen synthase kinase 3β (GSK3β) phosphorylation, and protein phosphatase 2A (PP2A) activity in hippocampal tissues.

Main Results:

  • Short-term CDK5 knockdown reversed βA aggregation by inhibiting GSK3β (Ser9) and activating PP2A.
  • Long-term CDK5 knockdown achieved persistent reduction in CDK5 levels and prevented βA aggregation.
  • The impact on amyloid precursor protein processing diminished with long-term treatment, suggesting a need for maintenance therapy.

Conclusions:

  • CDK5 is a validated therapeutic target for preventing or reducing amyloidosis in aged transgenic mice.
  • Sustained inhibition of CDK5 may require periodic booster treatments to maintain efficacy against amyloid precursor protein processing alterations.
Keywords:
Alzheimer's diseaseCDK5 RNAiGSK3β Ser9PP2Aβ-amyloid plaques

More Related Videos

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

12.8K
Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

7.2K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.6K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.4K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.4K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K